AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

IMPACT BIOMEDICAL INC. Director's Dealing 2024

Sep 17, 2024

35295_dirs_2024-09-16_77e9328a-3bb4-4bcf-add8-34f708c57fdb.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IMPACT BIOMEDICAL INC. (IBO)
CIK: 0001834105
Period of Report: 2024-09-16

Reporting Person: Heuszel Frank D (Director, CEO and President)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	95475	Direct